Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Insiders of US-listed companies filed 24 open-market purchases worth about $16.2M at 8 companies and 196 open-market sales worth about $328M.
Purchases
24
~$16.2M
Companies bought
8
Sales
196
~$328M
Companies sold
69
Alyeska Investment Group, L.P.
10% owner · Frontview REIT FVR · bought Oct 3, 2024
~$2.58M
Alyeska Investment Group, L.P.
10% owner · Frontview REIT FVR · bought Oct 3, 2024
~$2.58M
Many sales follow a plan set up months earlier, or cover taxes, and say little. They are listed here for completeness.
Director · Moonlake Immunotherapeutics MLTX · sold Oct 4, 2024
~$51.5M
Director · Moonlake Immunotherapeutics MLTX · sold Oct 4, 2024
~$41.8M
A day is the US Eastern day an insider’s Form 4 was accepted by the SEC, which is what US markets run on. A filing our nightly update picked up over a weekend is counted on the Friday before. Only open-market purchases and sales are counted; grants, option exercises, tax withholding and gifts are left out. Where a purchase is $50,000 or more and old enough, the chip shows how the stock did against the S&P 500 after it was reported. This lists what was filed and is not investment advice.
Alyeska Investment Group, L.P.
10% owner · Frontview REIT FVR · bought Oct 3, 2024
~$2.58M
Alyeska Investment Group, L.P.
10% owner · Frontview REIT FVR · bought Oct 3, 2024
~$2.58M
Alyeska Investment Group, L.P.
10% owner · Frontview REIT FVR · bought Oct 3, 2024
~$2.58M
Alyeska Investment Group, L.P.
10% owner · Frontview REIT FVR · bought Oct 3, 2024
~$2.58M
10% owner · Eton Pharmaceuticals ETON · bought Oct 8, 2024
~$211K
President and CEO · Angiodynamics ANGO · bought Oct 7, 2024
~$121K
10% owner · Eton Pharmaceuticals ETON · bought Oct 4, 2024
~$102K
10% owner · Eton Pharmaceuticals ETON · bought Oct 7, 2024
~$72K
Chief Executive Officer · Shattuck Labs STTK · bought Oct 7, 2024
~$44K
10% owner · Eton Pharmaceuticals ETON · bought Oct 8, 2024
~$28K
10% owner · Legacy Education LGCY · bought Oct 7, 2024
~$25K
Director · Mueller Water Products MWA · bought Oct 7, 2024
~$25K
Chief Executive Officer · Cardio Diagnostics Holdings CDIO · bought Sep 6, 2024
~$20K
10% owner · Eton Pharmaceuticals ETON · bought Oct 4, 2024
~$13K
EVP and CFO · Angiodynamics ANGO · bought Oct 8, 2024
~$10K
10% owner · Eton Pharmaceuticals ETON · bought Oct 7, 2024
~$9K
Director · Texas Pacific Land Corporation TPL · bought Oct 7, 2024
~$3K
Director · Texas Pacific Land Corporation TPL · bought Oct 7, 2024
~$2.9K
Director · Texas Pacific Land Corporation TPL · bought Oct 7, 2024
~$2K
Director · Texas Pacific Land Corporation TPL · bought Oct 7, 2024
~$2K
Director · Texas Pacific Land Corporation TPL · bought Oct 7, 2024
~$983
Director · Texas Pacific Land Corporation TPL · bought Oct 7, 2024
~$983
President and CEO · Trade Desk TTD · sold Oct 4, 2024
~$16.1M
Senior Vice President, CFO · Apple AAPL · sold Oct 4, 2024
~$13.4M
Director · ACM Research, Inc. ACMR · sold Oct 4, 2024
~$12.4M
Shanghai Science & Technology Venture Capital (Group) Co., Ltd.
10% owner · ACM Research, Inc. ACMR · sold Oct 4, 2024
~$12.3M
EVP & Group Pres, Cardiology · Boston Scientific BSX · sold Oct 7, 2024
~$11.3M
President and CEO · Trade Desk TTD · sold Oct 7, 2024
~$10.6M
President and CEO · Trade Desk TTD · sold Oct 7, 2024
~$9.45M
Director · Moonlake Immunotherapeutics MLTX · sold Oct 4, 2024
~$9.19M
See Remarks · Palantir PLTR · sold Oct 4, 2024
~$7.82M
Chairman, President & CEO · Boston Scientific BSX · sold Oct 7, 2024
~$6.97M
Chairman, President & CEO · Boston Scientific BSX · sold Oct 7, 2024
~$6.8M
Director · Moonlake Immunotherapeutics MLTX · sold Oct 4, 2024
~$6.63M
President and CEO · Trade Desk TTD · sold Oct 4, 2024
~$6.5M